Lacktman Quoted on New Mexico Legislation to Expand Telemedicine, Telehealth Coverage
02 April 2019
Partner Nate Lacktman was quoted in an article in mHealth Intelligence, “New Mexico OKs New Telemedicine Rules, Including Coverage Parity,” about a bill awaiting the governor’s signature that would expand telemedicine and telehealth coverage to include remote patient monitoring and store-and-forward services, as well as set coverage and payment guidelines.
Lacktman, who helped draft the bill, said roughly 36 states and the District of Columbia now have legislation in place setting coverage guidelines for health plans, 10 of which also mandate payment parity. “If signed into law, the bill should bring New Mexico to the forefront of telehealth coverage, benefitting patients and helping catalyze the growth of these technologies throughout the state,” he said.
Lacktman, who helped draft the bill, said roughly 36 states and the District of Columbia now have legislation in place setting coverage guidelines for health plans, 10 of which also mandate payment parity. “If signed into law, the bill should bring New Mexico to the forefront of telehealth coverage, benefitting patients and helping catalyze the growth of these technologies throughout the state,” he said.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”